首页 » GS1783 BioVector®大肠杆菌无痕RED重组基因组编辑菌株E. coli strain

GS1783 BioVector®大肠杆菌无痕RED重组基因组编辑菌株E. coli strain

  • 价  格:¥99860
  • 货  号:BioVector® GS1783
  • 产  地:北京
点击询问我要采购
 竭诚为您服务!
BioVector NTCC典型培养物保藏中心
联系人:Dr.Xu, Biovector NTCC Inc.

电话:400-800-2947 工作微信:1843439339 (QQ同号)

邮件:Biovector@163.com

手机:18901268599

地址:北京

已注册
 

BioVector® GS1783, a specialised Escherichia coli strain engineered by Gregory Smith for advanced BAC (Bacterial Artificial Chromosome) recombineering using the Red/ET system.


BioVector® GS1783 大肠杆菌重组工程菌株技术档案 / BioVector® GS1783 E. coli Recombineering Strain Datasheet

一、 背景与来源说明

GS1783 是专用于无痕重组工程(Scarless En Passant Recombineering)的大肠杆菌(E. coli)工程菌株,由 Nikolaus Osterrieder 实验室基于 E. coli DH10B 改造建立。该菌株染色体整合了受温敏型阻抑蛋白($cI857$)控制的 $\lambda$ Red 重组系统($\gamma, \beta, exo$),以及受 L-阿拉伯糖诱导启动子($P_{BAD}$)控制的 I-SceI 归巢内切酶(Homing Endonuclease)。GS1783 是对细菌人工染色体(BAC)、P1 衍生人工染色体(PAC)及大型病毒基因组(如疱疹病毒、痘病毒)进行高效率无痕点突变、基因敲除、片段插入及精准修饰的金标准宿主菌。

二、 基因型与核心机制

1. 菌株染色体基因型

DH10B derivative: F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 recA1 endA1 araD139 Δ(ara, leu)7697 galU galK λ- rpsL (StrR) npr+ [cI857 Δ(cro-bioA)::λ Red-PBAD-I-SceI]

2. En Passant 无痕重组工作原理

  • 第一步:Red 介导的插入(Primary Recombination)

    • 在 42°C 下短暂热激诱导表达 $\lambda$ Red 重组酶,将含有抗性标记(如 $Kan^R$)、侧翼 I-SceI 识别位点及两侧带有相同同源重复序列(Internal Duplication / Internal Homology)的 PCR 产物重组整合至 BAC 靶位点。

  • 第二步:I-SceI 切割与无痕切除(Secondary Recombination)

    • 添加 L-阿拉伯糖(L-Arabinose)诱导表达 I-SceI 内切酶,特异性引入双链断裂(DSB)。结合第二次 42°C 热激,促使菌株利用靶位点的内部同源重复序列发生分子内同源重组,精准切除抗性选择标记,完全不遗留任何异源序列(如 LoxP 或 FRT 疤痕)

三、 培养条件与无痕重组诱导指南

1. 基础培养与保存条件

  • 常规培养温度30°C(日常维持与扩增切勿超过 34°C,防止 $cI857$ 阻抑蛋白失活导致 Red 重组酶提前泄漏而引发质粒/基因组重组不稳定)。

  • 基础抗性:链霉素(Streptomycin, 50 $\mu\text{g/mL}$,源自染色体 $rpsL$ 突变)。

  • 保存条件:含 20% 甘油的 LB 菌液于 -80°C 深低温保存。

2. 标准无痕重组操作流程

  1. Red 重组与电转化

    • 将含有目标 BAC 的 GS1783 菌株于 30°C 培养至 $OD_{600} \approx 0.5 - 0.7$

    • 置于 42°C 水浴振荡热激 15 分钟 以诱导表达 Red 重组酶。

    • 冰浴冰镇 10–15 分钟后,用冰预冷的 10% 甘油洗涤 3 次,制备电转化感受态细胞并电转 PCR 重组片段。

  2. I-SceI 切割与标记切除

    • 挑选第一步成功重组的阳性克隆,接种于含 1% L-阿拉伯糖(L-Arabinose) 的无糖 LB 液体培养基中,30°C 振荡培养 1 小时(诱导 I-SceI 切割)。

    • 再次转入 42°C 水浴热激 15 分钟(启动第二次分子内重组)。

    • 30°C 继续复苏培养 1–2 小时,稀释涂布于无抗性 LB 平板上。

    • 通过平板影印(Replica Plating)筛选抗性丧失(如 $Kan^S$)的无痕突变阳性克隆。

四、 技术指标简表

参数描述
菌株类型大肠杆菌无痕重组工程专宿主菌(En Passant Recombineering Host)
生物安全等级BSL-1
染色体抗性Streptomycin Resistance (StrR, 50 $\mu\text{g/mL}$)
重组诱导方式42°C 热激($\lambda$ Red 重组系统) + 1% L-阿拉伯糖(I-SceI 内切酶)
主要重组载体BAC, PAC, 疱疹病毒(HSV/CMV/EBV)基因组、大质粒
应用优势真正实现无痕(Scarless)点突变、插入与敲除;不依赖传统限制性核酸内切酶与连接酶

BioVector® GS1783 E. coli Recombineering Strain Datasheet

1. Background & Context

The E. coli strain GS1783 is a specialized host designed for scarless En Passant recombineering in Bacterial Artificial Chromosomes (BACs), P1-derived Artificial Chromosomes (PACs), and large viral genomes (e.g., herpesvirus, poxvirus). Developed in Nikolaus Osterrieder's laboratory from E. coli DH10B, GS1783 features chromosome-integrated $\lambda$ Red recombination genes ($\gamma, \beta, exo$) controlled by the temperature-sensitive $cI857$ repressor, alongside an L-arabinose-inducible I-SceI homing endonuclease gene under the $P_{BAD}$ promoter. It represents the industry standard for performing precise point mutations, insertions, deletions, and tag integrations without leaving residual scar sequences.

2. Genotype & Recombineering Mechanism

2.1 Chromosomal Genotype

DH10B derivative: F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 recA1 endA1 araD139 Δ(ara, leu)7697 galU galK λ- rpsL (StrR) npr+ [cI857 Δ(cro-bioA)::λ Red-PBAD-I-SceI]

2.2 Principles of En Passant Mutagenesis

  • Step 1: Primary Red-Mediated Insertion

    • A brief heat shock at 42°C induces $\lambda$ Red recombinase to integrate a PCR fragment containing a selection marker (e.g., $Kan^R$), an adjacent I-SceI cleavage site, and flanking internal duplications (internal homology) into the target BAC locus.

  • Step 2: I-SceI Cleavage & Secondary Excision

    • Addition of L-arabinose induces I-SceI endonuclease expression, introducing a site-specific double-strand break (DSB). A second 42°C heat shock then activates Red-mediated intramolecular recombination between the internal repeats, seamlessly excising the selection cassette without leaving scar sequences (such as LoxP or FRT).

3. Culture & Induction Protocols

3.1 Growth Conditions & Antibiotic Maintenance

  • Routine Incubation Temperature: 30°C (Do NOT incubate above 34°C during routine culture to prevent premature activation of the $\lambda$ Red recombinase).

  • Selective Antibiotic: Streptomycin (50 $\mu\text{g/mL}$, encoded by chromosomal $rpsL$).

  • Storage: Store in LB containing 20% glycerol at -80°C.

3.2 En Passant Recombineering Workflow

  1. Primary Recombination & Electroporation:

    • Culture GS1783 harboring the target BAC at 30°C to $OD_{600} \approx 0.5 - 0.7$.

    • Transfer to a 42°C water bath for 15 minutes with shaking to induce Red recombinase.

    • Chill on ice for 10–15 min, wash 3 times with ice-cold 10% glycerol, and electroporate with the purified PCR product.

  2. I-SceI Induction & Marker Resolution:

    • Inoculate positive primary recombinants into glucose-free LB medium containing 1% L-Arabinose and shake at 30°C for 1 hour.

    • Transfer to a 42°C water bath for 15 minutes to induce secondary intramolecular recombination.

    • Outgrow at 30°C for 1–2 hours, then spread diluted cultures onto non-selective LB agar plates. Screen for marker loss (e.g., $Kan^S$) via replica plating.

4. Technical Data Summary

ParameterSpecification
Strain TypeSpecialized E. coli host for scarless en passant recombineering
Biosafety LevelBSL-1
Chromosomal ResistanceStreptomycin (StrR, 50 $\mu\text{g/mL}$)
Induction Triggers42°C heat-shock ($\lambda$ Red recombinase) + 1% L-Arabinose (I-SceI endonuclease)
Compatible ConstructsBACs, PACs, herpesvirus genomes (HSV/CMV/EBV), large plasmids
Key AdvantageScarless insertion, point mutation, and deletion without restriction enzymes or residual scar sites

    • λlambda

您正在向 biovector.net  发送关于产品 GS1783 BioVector®大肠杆菌无痕RED重组基因组编辑菌株E. coli strain 的询问

点击“立即发送”后,我们将在1个工作日内与您取得联系。